These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Allergic rhinitis and asthma: pathophysiological relationship and implications for treatment].
    Author: Diamant Z, Tarasevych S, Chandoesing P, van Wijk RG, de Groot H.
    Journal: Ned Tijdschr Geneeskd; 2006 Jan 14; 150(2):77-82. PubMed ID: 16440561.
    Abstract:
    Allergic rhinitis and asthma share various clinical, pathophysiological and immunological characteristics and often coexist. Recent studies provide evidence of cross-talk between both airway compartments, possibly by systemic signalling. These observations resulted in the concept of 'allergic airway disease', providing a rationale for systemic treatment. Presently, many novel systemic treatment modalities, including anti-IgE and phosphodiesterase-4 (PDE4) inhibitors, are being evaluated in clinical trials. In the Netherlands, there are currently two registered systemic therapies targeting the pathophysiological mechanisms of the united airway disease: leukotriene receptor antagonists and immunotherapy. These therapies are usually prescribed in combination with the standard pharmacotherapy.
    [Abstract] [Full Text] [Related] [New Search]